Cogent Biosciences
COGT
#2872
Rank
NZ$10.14 B
Marketcap
NZ$66.11
Share price
0.45%
Change (1 day)
402.61%
Change (1 year)

Market capitalization of Cogent Biosciences (COGT)

Market cap: NZ$10.14 Billion

As of January 2026 Cogent Biosciences has a market cap of NZ$10.14 Billion. This makes Cogent Biosciences the world's 2872th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Cogent Biosciences from 2018 to 2026

End of year Market Cap

Year Marketcap Change
2026NZ$10.14 B-1.52%
2025NZ$10.30 B579.77%
2024NZ$1.51 B89.32%
2023NZ$0.80 B-37.08%
2022NZ$1.27 B154.22%
2021NZ$0.50 B3.08%
2020NZ$0.48 B1381.02%
2019NZ$32.79 M-83.33%
2018NZ$0.19 B

End of Day market cap according to different sources

On Jan 14th, 2026 the market cap of Cogent Biosciences was reported to be:

NZ$9.37 Billion
by Nasdaq info icon info icon
NZ$10.10 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Onconova Therapeutics
ONTX
NZ$36.4 M-99.64%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
NZ$1.76 B-82.56%๐Ÿ‡บ๐Ÿ‡ธ USA